Cargando…

Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1

OBJECTIVE: The goal of the study was to identify brain and functional features associated with premanifest phases of adult-onset myotonic dystrophy type 1 (i.e., PreDM1). METHODS: This cross-sectional study included 68 healthy adults (mean age = 43.4 years, SD = 12.9), 13 individuals with PreDM1 (me...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Plas, Ellen, Koscik, Timothy R., Magnotta, Vincent, Cumming, Sarah A., Monckton, Darren, Gutmann, Laurie, Nopoulos, Peggy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075572/
https://www.ncbi.nlm.nih.gov/pubmed/33912661
http://dx.doi.org/10.1212/NXG.0000000000000577
Descripción
Sumario:OBJECTIVE: The goal of the study was to identify brain and functional features associated with premanifest phases of adult-onset myotonic dystrophy type 1 (i.e., PreDM1). METHODS: This cross-sectional study included 68 healthy adults (mean age = 43.4 years, SD = 12.9), 13 individuals with PreDM1 (mean age: 47.4 years, SD = 16.3), and 37 individuals with manifest DM1 (mean age = 45.2 years, SD = 9.3). The primary outcome measures included fractional anisotropy (FA), motor measures (Muscle Impairment Rating Scale, Grooved Pegboard, Finger-Tapping Test, and grip force), general cognitive abilities (Wechsler Adult Intelligence Scales), sleep quality (Scales for Outcomes in Parkinson's Disease–Sleep), and apathy (Apathy Evaluation Scale). RESULTS: Individuals with PreDM1 exhibited an intermediate level of white matter FA abnormality, where whole-brain FA was lower relative to healthy controls (difference of the estimated marginal mean [EMM(difference)] = 0.02, 95% confidence interval (CI) 0.01–0.03, p < 0.001), but the PreDM1 group had significantly higher FA than did individuals with manifest DM1 (EMM(difference) = 0.02, 95% CI 0.009–0.03, p < 0.001). Individuals with PreDM1 exhibited reduced performance on the finger-tapping task relative to control peers (EMM(difference) = 5.70, 95% CI 0.51–11.00, p = 0.03), but performance of the PreDM1 group was better than that of the manifest DM1 group (EMM(difference) = 5.60, 95% CI 0.11–11.00, p = 0.05). Hypersomnolence in PreDM1 was intermediate between controls (EMM(difference) = −1.70, 95% CI −3.10–0.35, p = 0.01) and manifest DM1 (EMM(difference) = −2.10, 95% CI −3.50–0.60, p = 0.006). CONCLUSIONS: Our findings highlight key CNS and functional deficits associated with PreDM1, offering insight in early disease course.